Yüklüyor......
Transfusion-dependent anaemia treatment using continuous erythropoietin receptor activator (epoetin β pegol) and roxadustat after darbepoetin treatment failure in low-risk myelodysplastic syndrome: a case report
Treatment of anaemia and reduction of transfusion are major therapeutic goals in patients with low-risk myelodysplastic syndrome (MDS). Although erythropoiesis-stimulating agents (ESAs) are widely used to reduce transfusion requirement, ESAs lose effectiveness within 12 months. We report a 65-year-o...
Kaydedildi:
| Yayımlandı: | Oxf Med Case Reports |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8143669/ https://ncbi.nlm.nih.gov/pubmed/34055362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omab026 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|